Quality of Life Perceptions Correlate with PASI Score Reductions Among Psoriasis Patients

Patients with moderate to severe plaque psoriasis given interleukin (IL)-17 or 23 inhibitors may adequately achieve target Dermatology Life Quality Index (DLQI) scores recommended by clinical guidelines, according to new findings, suggesting the possibility of implementing patient-reported…